[go: up one dir, main page]

ATE512988T1 - Antikörper gegen epcam und anwendungen davon - Google Patents

Antikörper gegen epcam und anwendungen davon

Info

Publication number
ATE512988T1
ATE512988T1 AT08759374T AT08759374T ATE512988T1 AT E512988 T1 ATE512988 T1 AT E512988T1 AT 08759374 T AT08759374 T AT 08759374T AT 08759374 T AT08759374 T AT 08759374T AT E512988 T1 ATE512988 T1 AT E512988T1
Authority
AT
Austria
Prior art keywords
epcam
antibodies
therapeutic
designated
high affinity
Prior art date
Application number
AT08759374T
Other languages
English (en)
Inventor
Anna Maria Anastasi
Fiorella Petronzelli
Santis Rita De
Saverio Alberti
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of ATE512988T1 publication Critical patent/ATE512988T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT08759374T 2007-04-04 2008-04-02 Antikörper gegen epcam und anwendungen davon ATE512988T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07105628 2007-04-04
PCT/EP2008/053913 WO2008122551A2 (en) 2007-04-04 2008-04-02 Anti-epcam antibody and uses thereof

Publications (1)

Publication Number Publication Date
ATE512988T1 true ATE512988T1 (de) 2011-07-15

Family

ID=38458122

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08759374T ATE512988T1 (de) 2007-04-04 2008-04-02 Antikörper gegen epcam und anwendungen davon

Country Status (21)

Country Link
US (1) US8318911B2 (de)
EP (1) EP2142570B1 (de)
JP (1) JP5631733B2 (de)
KR (1) KR101683884B1 (de)
CN (1) CN101970497B (de)
AT (1) ATE512988T1 (de)
AU (1) AU2008235566B2 (de)
BR (1) BRPI0810096A8 (de)
CA (1) CA2682296C (de)
CY (1) CY1111819T1 (de)
DK (1) DK2142570T3 (de)
EA (1) EA023679B1 (de)
ES (1) ES2367675T3 (de)
HR (1) HRP20110620T1 (de)
IL (1) IL201196A0 (de)
MX (1) MX2009010444A (de)
PL (1) PL2142570T3 (de)
PT (1) PT2142570E (de)
RS (1) RS52040B (de)
SI (1) SI2142570T1 (de)
WO (1) WO2008122551A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2513747C (en) 2003-01-24 2017-03-07 University Of Utah Methods of predicting mortality risk by determining telomere length
CN102439171B (zh) 2008-12-22 2017-07-14 犹他大学研究基金会 单色多重定量pcr
GB0909904D0 (en) * 2009-06-09 2009-07-22 Affitech As Product
EP3138581B1 (de) 2011-03-17 2019-01-02 The University of Birmingham Umgelenkte immuntherapie
EP2726870B1 (de) 2011-06-29 2018-10-03 Academia Sinica Erfassung, reinigung und freisetzung eines biologischen stoffes anahnd einer oberflächenbeschichtung
US9187558B2 (en) * 2012-03-02 2015-11-17 Academia Sinica Anti-epithelial cell adhesion molecule (EpCAM) antibodies and methods of use thereof
US9494500B2 (en) 2012-10-29 2016-11-15 Academia Sinica Collection and concentration system for biologic substance of interest and use thereof
WO2014190138A2 (en) 2013-05-22 2014-11-27 Telomere Diagnostics, Inc. Measures of short telomere abundance
TW201623605A (zh) 2014-04-01 2016-07-01 中央研究院 用於癌症診斷及預後之方法及系統
CN105381824B (zh) 2014-08-26 2019-04-23 中央研究院 收集器架构布局设计
CA2971169A1 (en) 2014-12-30 2016-07-07 Telomere Diagnostics, Inc. Multiplex quantitative pcr
US11098131B2 (en) 2015-07-31 2021-08-24 Sutro Biopharma, Inc. Anti-EpCAM antibodies, compositions comprising anti-EpCAM antibodies and methods of making and using anti-EpCAM antibodies
US10107726B2 (en) 2016-03-16 2018-10-23 Cellmax, Ltd. Collection of suspended cells using a transferable membrane
US11046782B2 (en) 2016-03-30 2021-06-29 Musc Foundation For Research Development Methods for treatment and diagnosis of cancer by targeting glycoprotein A repetitions predominant (GARP) and for providing effective immunotherapy alone or in combination
AU2017301826A1 (en) 2016-07-26 2019-03-14 Tessa Therapeutics Ltd. Chimeric antigen receptor
WO2020018964A1 (en) 2018-07-20 2020-01-23 Fred Hutchinson Cancer Research Center Compositions and methods for controlled expression of antigen-specific receptors
EP3897851A2 (de) 2018-12-17 2021-10-27 Revitope Limited Doppelimmunzell-engager
CN113597432B (zh) * 2019-04-22 2023-05-02 江苏恒瑞医药股份有限公司 抗EpCAM抗体及其应用
IL288753B1 (en) 2019-06-11 2025-01-01 Bioatla Llc Conditionally active anti-EPCAM antibodies, antibody fragments, their immunoconjugates and their uses
CN110950959B (zh) * 2020-02-25 2020-07-03 和铂医药(上海)有限责任公司 靶向EpCAM的抗体及其制备和应用
CN112094350B (zh) * 2020-06-01 2024-01-05 普众发现医药科技(上海)有限公司 可应用于肿瘤细胞捕获的小鼠抗细胞表面糖蛋白cd326的单克隆抗体
US20230357427A1 (en) 2020-08-19 2023-11-09 Shanghai Immunohead Biotechnology Co., Ltd Humanized antibody, chimeric antigen receptor, nucleic acid, vector, cell and use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675187A (en) 1983-05-16 1987-06-23 Bristol-Myers Company BBM-1675, a new antibiotic complex
US5525338A (en) 1992-08-21 1996-06-11 Immunomedics, Inc. Detection and therapy of lesions with biotin/avidin conjugates
IT1245748B (it) 1990-12-21 1994-10-14 Mini Ricerca Scient Tecnolog Preparazione includente anticorpi monoclonali biotinilati, avidina e biotina, per la diagnosi di affezioni tumorali e suo impiego
US5578287A (en) 1992-06-09 1996-11-26 Neorx Corporation Three-step pretargeting methods using improved biotin-active agent
JP3427871B2 (ja) 1996-06-24 2003-07-22 戸田工業株式会社 コバルト被着型針状磁性酸化鉄粒子粉末
ITRM20010079A1 (it) 2001-02-16 2002-08-16 Sigma Tau Ind Farmaceuti Amminoderivati della biotina e loro coniugati con chelanti macrociclici.
US20050180979A1 (en) * 2004-02-13 2005-08-18 Micromet Ag Anti-EpCAM immunoglobulins
US7435804B2 (en) * 2004-10-19 2008-10-14 Phage Biotechnology, Inc. Method for obtaining single chain antibodies to human interferon α2b

Also Published As

Publication number Publication date
CA2682296C (en) 2017-02-28
PT2142570E (pt) 2011-09-13
ES2367675T3 (es) 2011-11-07
US8318911B2 (en) 2012-11-27
CY1111819T1 (el) 2015-10-07
EA200970923A1 (ru) 2010-04-30
CA2682296A1 (en) 2008-10-16
PL2142570T3 (pl) 2011-11-30
BRPI0810096A8 (pt) 2017-12-26
RS52040B (en) 2012-04-30
JP5631733B2 (ja) 2014-11-26
KR101683884B1 (ko) 2016-12-07
KR20100016237A (ko) 2010-02-12
BRPI0810096A2 (pt) 2014-10-21
MX2009010444A (es) 2009-10-20
JP2010523096A (ja) 2010-07-15
EP2142570B1 (de) 2011-06-15
CN101970497A (zh) 2011-02-09
SI2142570T1 (sl) 2012-01-31
US20100092491A1 (en) 2010-04-15
AU2008235566B2 (en) 2013-06-06
CN101970497B (zh) 2017-05-10
HRP20110620T1 (hr) 2011-09-30
IL201196A0 (en) 2010-05-17
EA023679B1 (ru) 2016-06-30
WO2008122551A2 (en) 2008-10-16
EP2142570A2 (de) 2010-01-13
WO2008122551A3 (en) 2008-12-04
WO2008122551A9 (en) 2009-02-05
AU2008235566A1 (en) 2008-10-16
DK2142570T3 (da) 2011-10-03

Similar Documents

Publication Publication Date Title
ATE512988T1 (de) Antikörper gegen epcam und anwendungen davon
EA200900040A1 (ru) Молекулы антител, которые связываются с человеческим il-17
CY1121208T1 (el) Σκευασματα αντισωματος ναταλιζουμαμπης
CY1120398T1 (el) Ανθρωποποιημενα αντισωματα που αναγνωριζουν αλφα-συνουκλεϊνη
EA201201533A1 (ru) Prlr-специфическое антитело и его применения
UA113712C2 (xx) Антитіло до fap і способи його застосування
EP4364754A3 (de) Anti-b7-h3-antikörper und antikörper-wirkstoff-konjugate
EA201171060A1 (ru) Молекулы антител, обладающих специфичностью к человеческому ох40
NZ602256A (en) Monoclonal antibodies against the rgm a protein and uses thereof
CY1117236T1 (el) Μονοκλωνικα αντισωματα εναντι γλυπικανης-3
EA201390933A1 (ru) Антитела против мезотелина и иммуноконъюгаты
EA201070695A1 (ru) Молекулы гуманизированных антител, специфичных к il-31
PE20140232A1 (es) Proteinas de enlace antigeno capaz de enlazar linfopoyetina estromal timica
EP4434543A3 (de) Varianten von humanen igg1-fc-regionen und verwendungen davon
EA200900492A1 (ru) Молекулы антител, которые связываются с il-17a и il-17f
GT201200271A (es) Proteínas que se unen al tnf-a
EA201300978A1 (ru) Антитела к сеа
MX2018005512A (es) Agentes de union de esclerostina.
EA200801174A1 (ru) Антитела-миметики glp-2, полипептиды, композиции, способы и применения
NO20085362L (no) Hoyaffinitets humane og humaniserte anti-alfa5 beta1-integrin funksjonsblokkerende antistoffer med redusert immunogenisitet
EA201291180A1 (ru) Композиции и способы применения терапевтических антител против белка, родственного рецептору липопротеинов низкой плотности 6 (lrp6)
DE60321041D1 (de) Antikörper gegen krebsantigen tmeff2 und seine anwendungen
DE602006007967D1 (de) Gegen das gemeinsame epitop von mutierten p53 gerichtete humane synthetische einzelkettenantikörper und anwendungen davon
WO2017015634A3 (en) Constructs targeting psa peptide/mhc complexes and uses thereof
UA109148C2 (uk) Композиції на основі антитіла проти vegfr-3

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2142570

Country of ref document: EP